“ANTIBODY-DRUG CONJUGATES FOR TARGETED CANCER THERAPY”, Вопр. онкол., vol. 65, no. 6, pp. 777–784, Jun. 2019, doi: 10.37469/0507-3758-2019-65-6-777-784.